BUZZ-Protara Therapeutics slides after unveiling stock deal

Reuters12-10
BUZZ-Protara <a href="https://laohu8.com/S/LENZ">Therapeutics</a> slides after unveiling stock deal

** Protara Therapeutics TARA.O shares down 9.5% to $6.04 in extended trading on planned equity raise. Shares on Mon closed up 12.9% at $6.67

** Cancer and rare-disease treatment firm announces offering of stock and pre-funded warrants; deal size not disclosed

** It intends to use net offering proceeds to fund clinical development of TARA-002, and development of other clinical programs

** TARA shares on Thurs finished session up 70% at $6.02 after co said TARA-002 helped remove all signs of cancer in 72% of patients at six months of treatment for non-muscle invasive bladder cancer (NMIBC) in mid-stage study

** Co has ~20.6 mln shares outstanding for ~$137 mln market cap

** TD Cowen, Cantor, LifeSci Capital, Oppenheimer and Scotiabank jt bookrunners for offering

** TARA shares ended 2023 at $1.88

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment